Non-Hodgkin's lymphoma, CLL, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis
Haematology · 2018–2018
1decision
1medicine
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| rituximab Biosimilar brand of rituximab for all indications of the reference brand MabThera: non-Hodgkin's lymphoma, chronic lymphocytic leukaemia, rheumatoid arthritis,… | Mar 2018 | Recommended | input received Lymphoma Australia |
Who spoke
Lymphoma Australia
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.